Mumbai, Sept. 3 -- The agency has also affirmed the company's short-term rating at 'CARE A1 '.

CARE Ratings stated that the ratings for Vimta Labs' (Vimta's) bank facilities continue to reflect the company's established position in the contract research and testing organisation (CRTO) industry, backed by a seasoned management team with over four decades of industry experience.

Vimta benefits from a diversified service portfolio spanning pharmaceutical analytical testing and research, pre-clinical and clinical research, food and environmental testing, and electrical and electronic testing, supported by long-standing relationships with a broad client base.

The company had reported an improved financial performance in FY26, driven by robu...